UY30536A1 - SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION. - Google Patents
SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION.Info
- Publication number
- UY30536A1 UY30536A1 UY30536A UY30536A UY30536A1 UY 30536 A1 UY30536 A1 UY 30536A1 UY 30536 A UY30536 A UY 30536A UY 30536 A UY30536 A UY 30536A UY 30536 A1 UY30536 A1 UY 30536A1
- Authority
- UY
- Uruguay
- Prior art keywords
- solubilities
- active substances
- preparation
- application
- oral administration
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Sistema de liberacion farmacéutica controlada (independiente del pH) para administracion, particularmente oral, de sustancias activas con solubilidades dependientes del pH, comprendiendo material de nucleo conteniendo o consistiendo en uno o más modificadores del pH farmacéuticamente aceptables y las siguientes capas: a) opcionalmente una aislante, c) una primera comprendiendo uno o más polímeros insolubles en agua farmacéuticamente aceptables; d) una segunda comprendiendo por lo menos una sustancia activa con una solubilidad dependiente del pH; e) una tercera comprendiendo uno o más polímeros farmacéuticamente aceptables conteniendo grupos anionicos o no ionicos; y f) opcionalmente una cuarta, preferiblemente en forma de recubrimiento externo.Pharmaceutical controlled release system (independent of pH) for administration, particularly oral, of active substances with pH-dependent solubilities, comprising core material containing or consisting of one or more pharmaceutically acceptable pH modifiers and the following layers: a) optionally a insulator, c) a first comprising one or more pharmaceutically acceptable water insoluble polymers; d) a second one comprising at least one active substance with a pH dependent solubility; e) a third comprising one or more pharmaceutically acceptable polymers containing anionic or non-ionic groups; and f) optionally a fourth, preferably in the form of an external coating.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY30536A UY30536A1 (en) | 2007-08-13 | 2007-08-13 | SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY30536A UY30536A1 (en) | 2007-08-13 | 2007-08-13 | SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION. |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30536A1 true UY30536A1 (en) | 2008-03-31 |
Family
ID=39247293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30536A UY30536A1 (en) | 2007-08-13 | 2007-08-13 | SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION. |
Country Status (1)
Country | Link |
---|---|
UY (1) | UY30536A1 (en) |
-
2007
- 2007-08-13 UY UY30536A patent/UY30536A1/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR062321A1 (en) | CONTROLLED RELEASE SYSTEM AND METHOD TO MANUFACTURE | |
CY2019021I1 (en) | DRUG DELIVERY SYSTEM FOR THE DELIVERY OF POORLY WATER-SOLUBLE PHARMACEUTICALLY ACTIVE SUBSTANCES | |
WO2008146178A3 (en) | A novel tablet dosage form | |
CL2011000170A1 (en) | Solid and stabilized pharmaceutical composition comprising a pharmaceutically active ingredient, titanium oxide and a plasticizer; procedure to stabilize the pharmaceutical composition during a light irradiation. | |
CU20080052A7 (en) | SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF ACTIVE PRINCIPLE | |
CL2011002968A1 (en) | Hot melt extrusion dosage form of an active ingredient (a) included in a matrix comprising a polymer (c), the core having a morphological orientation orthogonal to the longitudinal direction of extension of the dosage form; and its preparation procedure. | |
WO2009032034A3 (en) | Stabilized picoplatin dosage form | |
CL2012001404A1 (en) | Pharmaceutical composition comprising drug-coated compressible microparticles, a taste-masking, modified-release coating comprising a water-insoluble polymer and a compressible coating with a non-polymeric sweetener thereon; composition of orally rapidly disintegrating tablets; Preparation method. | |
WO2009066146A3 (en) | Stable solutions of sparingly soluble actives | |
CY1118032T1 (en) | PROCESSES FOR COMMERCIAL PREPARATION OF PHARMACEUTICAL ACTIVE AGENT | |
NZ594311A (en) | Pharmaceutical composition comprising tamsulosin and solifenacin for oral administration | |
CY1116831T1 (en) | USE 24-norUDCA | |
ECSP14010605A (en) | SYSTEM FOR THE ADMINISTRATION OF DRUGS | |
UY31452A1 (en) | IMPROVED TABLET COATING | |
EP3858846A4 (en) | Nucleic acid nanocarrier medicament, preparation method therefor, pharmaceutical composition thereof, and use thereof | |
WO2009107136A3 (en) | Drug delivery device, system and method | |
NO20091467L (en) | Pharmaceutical formulations comprising clopidogrel | |
WO2012111996A3 (en) | Transdermal delivery system containing galantamine or salts thereof | |
RU2007136310A (en) | METHOD FOR PRODUCING NANOSIZED SYSTEM OF DELIVERY OF MEDICINES BASED ON SILICON DIOXIDE | |
ECSP109871A (en) | ORAL PHARMACEUTICAL SOLUTIONS CONTAINING TELBIVUDINE | |
ECSP099251A (en) | PHARMACEUTICAL FORMULATIONS | |
ES2531241T3 (en) | Trazodone-based stable liquid pharmaceutical composition | |
UY30536A1 (en) | SYSTEM OF CONTROLLED PHARMACEUTICAL RELEASE, PARTICULARLY ORAL ADMINISTRATION OF ACTIVE SUBSTANCES WITH SOLUBILITIES OF PH, PREPARATION AND APPLICATION. | |
AR059225A1 (en) | CITRATE SALT, PREPARATION PROCESS AND ITS ACTIVITY IN THERAPY | |
MA31227B1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING PHLOROGLUCINOL AND PARACETAMOL. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20170725 |